RxDoctor Payments Data

William Messer, MD

Family Medicine · Greenville, SCNPI 1700814985

Payments from drug & device makers

$4,296in general payments, 2019–2025

Across 244 payments — averaging $17.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$578
  • Novo Nordisk$481
  • Amgen$440
  • AbbVie$426
  • GSK$279
  • Abbott$269
  • plus $2K from 38 others

What the payments were for

  • Food & beverage$4,296100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,296 in reported general payments places this provider in the 80th percentile of 2,153 family medicine providers in South Carolina.

See all family medicine providers in South Carolina

Medicare billing

Part B allowed, 2024
$64,743
Medicare patients
196
Services billed
973

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide56$80,921
Synjardy XrEmpagliflozin/Metformin Hcl29$43,080
Tresiba Flextouch U-200Insulin Degludec23$28,100
Repatha SureclickEvolocumab37$28,070
EliquisApixaban22$27,654
JardianceEmpagliflozin16$27,100
OzempicSemaglutide15$27,081
XareltoRivaroxaban18$11,535
Xigduo XrDapaglifloz Propaned/Metformin11$8,353
Rosuvastatin Calcium271$4,119
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$3,615
Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide65$3,407
Atorvastatin Calcium256$2,527
Valsartan70$2,463
Albuterol Sulfate HfaAlbuterol Sulfate46$1,865

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$122$80,92156 claims
Boehringer IngelheimSynjardy Xr, Jardiance$15$70,18045 claims
PfizerEliquis$166$27,65422 claims
Novo NordiskOzempic$481$27,08115 claims
Johnson & JohnsonXarelto$36$11,53518 claims
AbbVieSynthroid$426$1,40415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,153 family medicine providers in South Carolina.

Other family medicine in Greenville

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →